Sze KM - Search Results

1

PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis.

Ko FC, Chan LK, Sze KM, Yeung YS, Tse EY, Lu P, Yu MH, Ng IO, Yam JW. Ko FC, et al. Among authors: sze km. Nat Commun. 2013;4:1618. doi: 10.1038/ncomms2604. Nat Commun. 2013. PMID: 23511482 Free article.

2

Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells.

Sze KM, Ching YP, Jin DY, Ng IO. Sze KM, et al. J Biomed Sci. 2004 Nov-Dec;11(6):920-7. doi: 10.1007/BF02254377. J Biomed Sci. 2004. PMID: 15591789

3

Role of a novel splice variant of mitotic arrest deficient 1 (MAD1), MAD1beta, in mitotic checkpoint control in liver cancer.

Sze KM, Ching YP, Jin DY, Ng IO. Sze KM, et al. Cancer Res. 2008 Nov 15;68(22):9194-201. doi: 10.1158/0008-5472.CAN-08-2600. Cancer Res. 2008. PMID: 19010891

4

Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.

Hui IC, Tung EK, Sze KM, Ching YP, Ng IO. Hui IC, et al. Among authors: sze km. Liver Int. 2010 Jan;30(1):65-75. doi: 10.1111/j.1478-3231.2009.02117.x. Epub 2009 Oct 20. Liver Int. 2010. PMID: 19845851 Free article.

5

Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.

Sze KM, Wong KL, Chu GK, Lee JM, Yau TO, Ng IO. Sze KM, et al. Hepatology. 2011 May;53(5):1558-69. doi: 10.1002/hep.24232. Hepatology. 2011. PMID: 21520171

6

Nuclear-targeted deleted in liver cancer 1 (DLC1) is less efficient in exerting its tumor suppressive activity both in vitro and in vivo.

Chan LK, Ko FC, Sze KM, Ng IO, Yam JW. Chan LK, et al. Among authors: sze km. PLoS One. 2011;6(9):e25547. doi: 10.1371/journal.pone.0025547. Epub 2011 Sep 26. PLoS One. 2011. PMID: 21966542 Free PMC article.

7

Proline-rich acidic protein 1 (PRAP1) is a novel interacting partner of MAD1 and has a suppressive role in mitotic checkpoint signalling in hepatocellular carcinoma.

Sze KM, Chu GK, Mak QH, Lee JM, Ng IO. Sze KM, et al. J Pathol. 2014 May;233(1):51-60. doi: 10.1002/path.4319. Epub 2014 Jan 27. J Pathol. 2014. PMID: 24374861

8

Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma.

Chan LK, Chiu YT, Sze KM, Ng IO. Chan LK, et al. Among authors: sze km. Oncotarget. 2015 Aug 28;6(25):20964-76. doi: 10.18632/oncotarget.4122. Oncotarget. 2015. PMID: 26035355 Free PMC article.

9

Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.

Wong CM, Wei L, Law CT, Ho DW, Tsang FH, Au SL, Sze KM, Lee JM, Wong CC, Ng IO. Wong CM, et al. Among authors: sze km. Hepatology. 2016 Feb;63(2):474-87. doi: 10.1002/hep.28304. Epub 2015 Dec 14. Hepatology. 2016. PMID: 26481868

10

RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.

Ma W, Sze KM, Chan LK, Lee JM, Wei LL, Wong CM, Lee TK, Wong CC, Ng IO. Ma W, et al. Among authors: sze km. Oncotarget. 2016 Jul 5;7(27):41445-41459. doi: 10.18632/oncotarget.9441. Oncotarget. 2016. PMID: 27213590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters